eure KARE launch innovation-drive Start-up studio of Monaco To application synthetic biology of tackleis doing deadly environment challenges
Luxembourg,Belgium, and Paris, France – 15 November 2022: eureKARE (the “Company”), an innovative investment company in disruptive synthetic biology applications, today announced a focus on supporting and housing synthetic biology projects aimed at tackling the world’s most pressing problems. , announced the launch of an innovation-driven startup studio in Monaco. environmental issues. This expands eureKARE’s network of synthetic biology studios, each with a different theme, into a European innovation hotspot. The Monaco studio will be the hub of a network of innovations focused on climate change.
eureKARE’s Synthetic Biology Studio model is a novel and flexible approach to the creation of biotech start-ups, identifying, selecting and cultivating high-quality European science to create a unique ecosystem, resources and expertise. Putting knowledge behind scientists and concepts to create and develop new enterprises.
Alexandre Mouradian, Chairman, Founder and CEO of eureKARE said: “To promoting synTechic biologicstrategy based onwe will see Occurrence of nnew Sustainable solutions and new economic models will prove invaluable in addressing some of the world’s greatest environmental challengesExcellence in marine research implementation in monaco was Key determinant Monaco our symbio Start-up hub. I can’t wait to see where this takes us, with the support and insight of eureKARE.”
The Monaco studio will focus on fostering projects dedicated to the better conservation and more sustainable use of environmental resources. Plastic pollution is one example of a serious environmental problem, with approximately 400 million tonnes of plastic waste generated each year. Engineering new microorganisms to digest plastic pollutants and synthesize sustainable plastics is one of the projects expected to be supported by eureKARE’s Monaco studio. Another project under evaluation is using synthetic biology to enable certain marine organisms to sense the presence of contaminants in seawater and trigger bioremediation responses.
surge Pampfer, Chief Scientific Officer at eureKARE, said:: “among the most exciting S.ofB.IO Start-up projects eureKARE is considering investing in Monaco and their objectivesEd In development cutting edge better technology Harness To protect our marine resources,Tell stage. This is due to of Increased need for better protection our sea is wide an array of rupture application symbio available in this area.”
– ends –
About eureKARE
eureKARE is an investment company focused on financing and developing synthetic biology innovations across Europe. Driven by the belief that synthetic biology holds the key to many of the world’s most pressing health and environmental challenges, eureKARE’s experienced team is dedicated to building the enterprise of the future. The focus is on leveraging Europe’s untapped leadership. eureKARE advocates a new model of startup creation and development to create a dynamic ecosystem of early and late stage ventures through a network of biotech studios. eureKARE’s studios act as a bridge between academia and industry to help drive innovation to companies that have access to all the ingredients they need to grow, thrive and benefit society. .
contact address
eureKARE SA
Cátia Dourado, Communications Manager
catia.dourado@eurekare.eu
strategic communication plan – Media contact point
Amber Fennell, Skyna Verge, Genevieve Wilson
eurekare@consilium-comms.com
